|
|
 |
|
Viewing report
|
|
|
Aastrom Biosciences Inc (29-Mar-2011)
Directors Deals Ltd, March 2011, Pages: 1
Ronald Cresswell, (Non-Executive) of Aastrom Biosciences Inc [market cap £46million] maiden bought 20,000 shares at 2.190USD, holding is now 20,000 shares; representing 0.071 percent of the shares on issue. Total trade value was £26,848 and the significance rating is 60/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
